
Friday, November 08, 2019 12:48:56 PM
RAPT
New York Yankees and Duke Basketball

Liked By
Spread the love. Be the first to like this post!
Recent RAPT News
- Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 01/26/2023 07:30:29 PM
- Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 01/20/2023 11:34:11 PM
- Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 01/17/2023 09:11:47 PM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 01/09/2023 01:04:00 PM
- RAPT Therapeutics to Present at the 41st Annual J.P. Morgan Healthcare Conference • GlobeNewswire Inc. • 01/03/2023 01:00:00 PM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 12/12/2022 09:03:57 PM
- SVB Securities Keeps Their Buy Rating on RAPT Therapeutics (RAPT) • TipRanks • 12/12/2022 11:35:26 AM
- RAPT Therapeutics Presents Update from its Phase 1/2 Clinical Trial for FLX475 as Monotherapy and in Combination with Pembrolizumab in Patients with Advanced Cancer • GlobeNewswire Inc. • 12/08/2022 11:30:00 AM
- RAPT Therapeutics to Present FLX475 Phase 1/2 Data at the European Society for Medical Oncology (ESMO) Immuno-Oncology Annual Congress • GlobeNewswire Inc. • 12/01/2022 12:05:22 AM
- Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) • Edgar (US Regulatory) • 11/18/2022 09:53:04 PM
- RAPT Therapeutics Tanks on $75M Public Offering • TipRanks • 11/18/2022 11:39:00 AM
- RAPT Therapeutics Announces Pricing of Public Offering of Common Stock • GlobeNewswire Inc. • 11/18/2022 02:38:04 AM
- RAPT Therapeutics Announces Proposed Public Offering of Common Stock • GlobeNewswire Inc. • 11/17/2022 09:24:51 PM
- SVB Securities Keeps Their Buy Rating on RAPT Therapeutics (RAPT) • TipRanks • 11/14/2022 03:55:48 AM
- Quarterly Report (10-q) • Edgar (US Regulatory) • 11/10/2022 01:22:24 PM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 11/10/2022 01:13:00 PM
- RAPT Therapeutics Reports Third Quarter 2022 Financial Results • GlobeNewswire Inc. • 11/10/2022 01:00:00 PM
- RAPT Therapeutics to Participate in Several Upcoming Investor Conferences • GlobeNewswire Inc. • 11/09/2022 01:00:00 PM
- Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 11/03/2022 10:45:29 PM
- Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 10/04/2022 04:48:02 PM
- RAPT Therapeutics Strengthens Leadership Team with Two New Key Hires • GlobeNewswire Inc. • 09/28/2022 12:00:00 PM
- Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 09/06/2022 11:55:54 PM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 09/06/2022 08:22:24 PM
- RAPT Therapeutics to Participate in Several Upcoming Investor Conferences in September • GlobeNewswire Inc. • 08/31/2022 12:00:00 PM
- RAPT Therapeutics (RAPT) Receives a Buy from SVB Securities • TipRanks • 08/11/2022 08:35:41 PM
1606 Corp Now Trading under Ticker CBDW, Management Announces First Acquisition • CBDW • Jan 27, 2023 11:59 AM
IQST - iQSTEL Reminds Shareholders To Get Their Votes In Before Annual Meeting Next Week On January 31, 2023 • IQST • Jan 26, 2023 9:53 AM
Nextech AR's AI-Powered CAD to Poly Toggle3D Launches Major Technology Advancements • ARWYF • Jan 26, 2023 8:46 AM
UCASU jump-starts its plan of NASDAQ or NYSE up-listing in 2023 • UCASU • Jan 26, 2023 7:21 AM
Kaya Holdings, Inc. (OTCQB: KAYS) Launches Fifth Dimension Therapeutics™ to seek to Provide Innovative Psychedelic-Based Treatments for Depression and Anxiety Related Conditions and Address the Growing Multi-Billion Dollar Global Psychedelics Market • KAYS • Jan 25, 2023 10:53 AM
B2 Digital's B2 SPORTS NETWORK (B2SN) Expands Distribution to Europe, Russia, and Asia with StayLIVE Agreement • BTDG • Jan 25, 2023 10:00 AM